About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
As the leading biopharmaceutical trade association, PhRMA is committed to driving efforts to address these inequities and push for better health outcomes for underserved communities. In 2020 we committed to taking on this leadership role and created the PhRMA Equity Initiative. Since then, we have dedicated significant time and resources toward areas where we can drive real progress--namely health equity, clinical trial diversity and talent.
We know meaningful change can only arise when we work in good partnership and rebuild trust with the communities who have been impacted by inequities for years. That’s why we’re proud to show that 2022 was a year of collaboration and action. Ultimately, PhRMA’s enduring commitment is to be a force in the push for equity. The partnerships, grants, events, and advocacy summarized in this report represent the progress we’ve made built on the commitments we keep.
Progress Built on Commitment: PhRMA Equity in 2022 image
Report
Progress Built on Commitment: PhRMA Equity in 2022
Progress Built on Commitment: PhRMA Equity in 2022 image